Anticoagulants therapy warfarin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy3

Vena Cava, Inferior Leg Heart Atria

Diseases41

Thromboembolism Hemorrhage Pulmonary Embolism Thrombophlebitis Venous Thrombosis Atrial Fibrillation Thrombosis Venous Thromboembolism Hematoma Thrombophilia Recurrence Blood Coagulation Disorders Stroke Embolism Hematoma, Subdural Antiphospholipid Syndrome Intracranial Embolism and Thrombosis Cerebral Hemorrhage Cerebrovascular Disorders Heart Diseases Postoperative Hemorrhage Postthrombotic Syndrome Sinus Thrombosis, Intracranial Hematoma, Epidural, Spinal Pregnancy Complications, Cardiovascular Ischemic Attack, Transient Brain Ischemia Postoperative Complications Carotid Artery, Internal, Dissection Myocardial Infarction Intracranial Hemorrhages Hypoprothrombinemias Cerebral Infarction Activated Protein C Resistance Acute Disease Vitamin K Deficiency Protein S Deficiency Antithrombin III Deficiency Chronic Disease Protein C Deficiency Neoplasms

Chemicals and Drugs57

Warfarin Anticoagulants Phenindione Acenocoumarol Phenprocoumon Vitamin K Epoxide Reductases Heparin, Low-Molecular-Weight Dicumarol Vitamin K Heparin beta-Alanine Lupus Coagulation Inhibitor Aspirin Antithrombins Rodenticides Prothrombin Blood Coagulation Factors Coumarins Platelet Aggregation Inhibitors Fibrinolytic Agents Protein C 4-Hydroxycoumarins Fibrin Fibrinogen Degradation Products Enoxaparin Benzimidazoles Thiophenes Factor Xa Pipecolic Acids Antithrombin III Thrombin Factor X Factor VII Mixed Function Oxygenases Protein S Thromboplastin Nadroparin Benzylamines Thrombomodulin Azetidines Aryl Hydrocarbon Hydroxylases Ticlopidine Antibodies, Antiphospholipid Antibodies, Anticardiolipin Vitamin K 1 Pyridones Coagulants Hirudins Heparin Antagonists Factor V beta 2-Glycoprotein I Factor Va Antithrombin Proteins Dalteparin Carbon-Carbon Ligases Morpholines Dermatan Sulfate Heparin Cofactor II

Analytical, Diagnostic and Therapeutic Techniques and Equipment32

Prothrombin Time International Normalized Ratio Administration, Oral Blood Coagulation Tests Partial Thromboplastin Time Drug Monitoring Heart Valve Prosthesis Treatment Outcome Follow-Up Studies Thrombin Time Risk Factors Phlebography Vena Cava Filters Oral Surgical Procedures Prospective Studies Retrospective Studies Tomography, X-Ray Computed Drug Therapy Drug Administration Schedule Thrombolytic Therapy Randomized Controlled Trials as Topic Drug Therapy, Combination Risk Assessment Incidence Clinical Trials as Topic Echocardiography, Transesophageal Risk Double-Blind Method Drug Dosage Calculations Probability Cerebral Angiography Prognosis

Phenomena and Processes11

Prothrombin Time Blood Coagulation Partial Thromboplastin Time Thrombin Time Time Factors Hemostasis Drug Interactions Dose-Response Relationship, Drug Risk Probability Herb-Drug Interactions

Disciplines and Occupations1

Pharmacogenetics

Information Science1

Health Care15

Treatment Outcome Follow-Up Studies Risk Factors Prospective Studies Retrospective Studies Rodent Control Randomized Controlled Trials as Topic Risk Assessment Incidence Clinical Trials as Topic Risk Practice Guidelines as Topic Age Factors Double-Blind Method Probability

Geographicals1

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care Geographicals

Warfarin Anticoagulants Phenindione Prothrombin Time Acenocoumarol Thromboembolism International Normalized Ratio Hemorrhage Phenprocoumon Pulmonary Embolism Thrombophlebitis Venous Thrombosis Vitamin K Epoxide Reductases Heparin, Low-Molecular-Weight Dicumarol Vitamin K Heparin Blood Coagulation Atrial Fibrillation Administration, Oral Thrombosis Venous Thromboembolism beta-Alanine Blood Coagulation Tests Lupus Coagulation Inhibitor Hematoma Aspirin Antithrombins Partial Thromboplastin Time Rodenticides Prothrombin Blood Coagulation Factors Thrombophilia Drug Monitoring Coumarins Platelet Aggregation Inhibitors Fibrinolytic Agents Recurrence Blood Coagulation Disorders Protein C 4-Hydroxycoumarins Fibrin Fibrinogen Degradation Products Stroke Enoxaparin Embolism Hematoma, Subdural Heart Valve Prosthesis Treatment Outcome Antiphospholipid Syndrome Intracranial Embolism and Thrombosis Benzimidazoles Thiophenes Cerebral Hemorrhage Factor Xa Pipecolic Acids Follow-Up Studies Thrombin Time Time Factors Antithrombin III Risk Factors Thrombin Factor X Phlebography Vena Cava Filters Hemostasis Factor VII Mixed Function Oxygenases Cerebrovascular Disorders Oral Surgical Procedures Protein S Thromboplastin Nadroparin Heart Diseases Postoperative Hemorrhage Prospective Studies Postthrombotic Syndrome Drug Interactions Retrospective Studies Sinus Thrombosis, Intracranial Hematoma, Epidural, Spinal Benzylamines Thrombomodulin Azetidines Pregnancy Complications, Cardiovascular Aryl Hydrocarbon Hydroxylases Tomography, X-Ray Computed Ischemic Attack, Transient Drug Therapy Drug Administration Schedule Ticlopidine Pharmacogenetics Dose-Response Relationship, Drug Thrombolytic Therapy Antibodies, Antiphospholipid Rodent Control Randomized Controlled Trials as Topic Drug Therapy, Combination Brain Ischemia Postoperative Complications Vena Cava, Inferior

No FAQ available that match "anticoagulants therapy warfarin"